Name
University of Phoenix
NSG/507 Social Justice and Information Systems for Population Health
Prof. Name
Date
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that causes inflammation and ulcers in the lining of the colon and rectum. The most common symptoms include bloody diarrhea, rectal bleeding, abdominal pain, bowel urgency, fatigue, and unintended weight loss. Although there is currently no permanent cure, medications, lifestyle management, regular monitoring, and surgery when necessary can help control inflammation, maintain remission, prevent complications, and improve quality of life.
Ulcerative colitis is one of the two major types of inflammatory bowel disease (IBD), the other being Crohn’s disease. Unlike Crohn’s disease, which can affect any part of the digestive tract, ulcerative colitis affects the large intestine. In most cases, inflammation begins in the rectum and extends continuously into the colon.
Ulcerative colitis is a long-term inflammatory condition affecting the colon and rectum. It occurs when an abnormal immune response causes persistent inflammation in the intestinal lining. Continued inflammation can result in ulcers, bleeding, swelling, and changes in normal bowel function.
UC usually follows a relapsing and remitting course. This means symptoms may become active during a flare-up and then improve or disappear during periods of remission. The severity and frequency of symptoms vary from person to person.
Although ulcerative colitis is often described as an autoimmune-related condition, current medical understanding more precisely considers it an immune-mediated inflammatory disease involving genetic, immune, environmental, and gut-microbiome factors.
The symptoms of ulcerative colitis depend on how much of the colon is affected and how severe the inflammation is. Some people have mild symptoms, while others experience severe inflammation that requires urgent treatment or hospitalization.
Common ulcerative colitis symptoms include:
Persistent diarrhea, often with blood or mucus
Rectal bleeding
Abdominal pain or cramping
An urgent need to have a bowel movement
Frequent bowel movements
A feeling of incomplete bowel evacuation
Fatigue
Loss of appetite
Unintentional weight loss
Fever, particularly during severe disease
Some people may also develop symptoms outside the digestive system, including joint pain, skin problems, eye inflammation, or certain liver and bile duct disorders.
Doctors classify ulcerative colitis according to the location and extent of inflammation in the colon. The main types range from inflammation limited to the rectum to inflammation involving the entire colon.
Ulcerative proctitis occurs when inflammation is limited to the rectum. It is generally the most limited form of ulcerative colitis. Rectal bleeding, rectal discomfort, urgency, and an increased need to have bowel movements are common symptoms.
Proctosigmoiditis affects the rectum and sigmoid colon, which is the lower portion of the large intestine. Symptoms may include bloody diarrhea, abdominal cramping, rectal bleeding, and bowel urgency.
Left-sided colitis extends from the rectum through the descending colon. People with this form may experience diarrhea, rectal bleeding, abdominal pain—often on the left side—and unintended weight loss.
Pancolitis, also called extensive colitis, affects most or all of the colon. Because a larger area is inflamed, symptoms may be more severe and can include frequent bloody diarrhea, significant abdominal discomfort, fatigue, fever, and weight loss.
Acute severe ulcerative colitis is a serious complication of active disease rather than simply a separate location-based type. It involves severe inflammation and can cause frequent bloody stools, fever, rapid heart rate, anemia, dehydration, and other systemic complications. It requires prompt medical assessment and often hospital-based treatment.
The exact cause of ulcerative colitis is not fully understood. Researchers believe it develops through an interaction between genetic susceptibility, an abnormal immune response, environmental factors, and changes in the microorganisms living in the digestive tract.
In a healthy digestive system, the immune system helps protect the body from harmful organisms while maintaining tolerance toward beneficial gut bacteria and normal intestinal tissue. In ulcerative colitis, this balance becomes disrupted, resulting in an inappropriate inflammatory response.
Ulcerative colitis is not caused by stress or a particular food alone. However, stress, diet, infections, medications, and other factors may influence symptoms or contribute to flare-ups in some individuals.
Several factors may increase the likelihood of developing ulcerative colitis, although no single factor directly causes the disease.
Important risk factors and associations include:
A family history of ulcerative colitis or other inflammatory bowel disease
Genetic susceptibility
Younger age at onset, although UC can develop at any age
Certain environmental exposures
Alterations in the gut microbiome
Certain demographic or ancestral backgrounds
Having a risk factor does not mean a person will develop ulcerative colitis. The condition is believed to result from multiple interacting biological and environmental influences.
Ulcerative colitis primarily affects the inner lining, or mucosa, of the colon and rectum. Inflammation can cause the intestinal lining to become swollen, fragile, and ulcerated.
When inflammation interferes with normal colon function, the large intestine may have difficulty absorbing water and forming stool normally. This can contribute to diarrhea, urgency, bleeding, and frequent bowel movements.
Persistent inflammation can also cause complications such as anemia, nutritional deficiencies, and changes in the structure and function of the colon. Long-standing inflammatory activity is associated with an increased risk of colorectal cancer.
Proper treatment and monitoring are important because uncontrolled or long-standing ulcerative colitis can cause serious complications.
Potential complications include:
Colorectal cancer
Severe bleeding
Anemia
Dehydration
Malnutrition
Osteoporosis or reduced bone density
Toxic megacolon
Bowel perforation
Blood clots
Severe disease requiring hospitalization
Reduced physical and emotional quality of life
The risk of colorectal cancer generally increases with longer disease duration, particularly when extensive colitis and ongoing inflammation are present. For this reason, appropriate colorectal cancer surveillance is an important part of long-term UC management.
There is no single test that independently confirms every case of ulcerative colitis. Healthcare professionals generally combine the patient’s symptoms and medical history with blood tests, stool testing, endoscopy, biopsies, and imaging when appropriate.
The evaluation usually begins with questions about bowel habits, rectal bleeding, abdominal pain, weight changes, family history of IBD, medications, and previous gastrointestinal problems.
A physical examination can help identify signs of dehydration, abdominal tenderness, anemia, or other complications.
Blood tests may help identify inflammation, anemia, infection, or nutritional problems. Tests can include a complete blood count, inflammatory markers, electrolyte levels, liver tests, and other studies based on the patient’s symptoms.
Stool testing can help identify infections and other causes of diarrhea. Fecal calprotectin may also be used to detect intestinal inflammation and can help distinguish inflammatory bowel disease from some non-inflammatory gastrointestinal conditions.
Colonoscopy allows a healthcare professional to directly examine the colon and rectum and identify inflammation, ulcers, bleeding, and other abnormalities. During the procedure, tissue samples can be collected for microscopic examination.
Endoscopic findings combined with biopsy results are important for confirming ulcerative colitis and distinguishing it from other causes of intestinal inflammation.
CT scans or MRI studies may be used when doctors need to evaluate complications or consider other gastrointestinal conditions. Imaging is not always required to diagnose uncomplicated ulcerative colitis.
The goals of ulcerative colitis treatment are to control active inflammation, relieve symptoms, achieve and maintain remission, prevent complications, and support long-term quality of life.
Treatment depends on the location and severity of disease, previous treatment response, other health conditions, and individual patient preferences.
Aminosalicylates, commonly called 5-ASA medications, such as mesalamine, are frequently used for mild to moderate ulcerative colitis. They can be administered orally, rectally, or through a combination of approaches depending on the location of inflammation.
Corticosteroids may be prescribed for moderate to severe flare-ups when rapid control of inflammation is needed. Because long-term corticosteroid use can cause significant adverse effects, these medications are generally used for limited periods rather than as a maintenance treatment.
Immunomodulatory medications can alter immune activity and may be used in selected patients to help maintain disease control or reduce dependence on corticosteroids.
Biologic medications target specific components of the immune and inflammatory pathways involved in ulcerative colitis. They may be prescribed for moderate to severe disease or when other treatments do not provide adequate control.
Janus kinase (JAK) inhibitors and other targeted small-molecule therapies are options for selected adults with moderate to severe ulcerative colitis. The choice of medication depends on factors such as disease severity, previous treatments, safety considerations, and patient preferences.
Surgery may be considered when ulcerative colitis does not respond adequately to medication or when serious complications develop. It may also be recommended in certain cases of colorectal cancer or precancerous changes.
Surgical removal of the colon and rectum can eliminate the diseased intestinal tissue and is considered a potentially curative treatment for the intestinal manifestations of ulcerative colitis.
Diet does not cause ulcerative colitis, and there is no single diet that works for everyone with the disease. However, nutrition can play an important role in maintaining health and managing symptoms.
During a flare-up, some people find that certain foods worsen diarrhea, cramping, or bloating. Keeping a food and symptom diary can help identify individual triggers.
Depending on individual needs, healthcare professionals may recommend adjustments involving fiber, dairy products, high-fat foods, caffeine, alcohol, or other foods. People with significant weight loss, nutritional deficiencies, or restrictive diets may benefit from working with a registered dietitian experienced in IBD.
Other helpful disease-management strategies include staying adequately hydrated, taking medications as prescribed, attending follow-up appointments, avoiding smoking, maintaining appropriate physical activity, and addressing stress and emotional well-being.
There is currently no proven way to prevent ulcerative colitis because its exact cause remains unknown. However, people diagnosed with UC can take steps to reduce complications and maintain disease control.
Effective long-term management generally includes:
Following the prescribed treatment plan
Taking medications consistently
Monitoring symptoms and reporting changes promptly
Attending gastroenterology appointments
Maintaining adequate nutrition and hydration
Participating in recommended colorectal cancer screening
Managing stress and maintaining overall physical health
Treatment should not be stopped simply because symptoms improve. Clinical remission does not necessarily mean that intestinal inflammation has completely resolved.
A flare-up occurs when ulcerative colitis becomes active after a period of improvement or remission. Symptoms may include increased bowel frequency, bloody diarrhea, abdominal pain, urgency, fatigue, or fever.
The severity of a flare-up can vary substantially. A significant increase in bloody stools, severe abdominal pain, fever, dehydration, rapid heart rate, or other signs of serious illness requires prompt medical evaluation.
Patients should work with their healthcare providers to develop an individualized plan for recognizing and managing worsening symptoms.
Long-standing ulcerative colitis is associated with an increased risk of colorectal cancer, particularly when a substantial portion of the colon is affected and inflammation has been present for many years.
The risk varies according to factors such as disease duration, extent of colonic involvement, degree of inflammation, family history, and the presence of certain precancerous changes.
Because of this increased risk, people with longstanding ulcerative colitis may need regular colonoscopic surveillance according to recommendations from their gastroenterology team.
Ulcerative colitis and Crohn’s disease are both forms of inflammatory bowel disease, but they differ in important ways.
Ulcerative colitis is limited to the colon and rectum and typically produces continuous inflammation beginning in the rectum. Crohn’s disease can affect any part of the gastrointestinal tract and often produces patchy areas of inflammation.
Another important distinction is the depth of inflammation. Ulcerative colitis primarily affects the mucosal lining, whereas Crohn’s disease can involve deeper layers of the intestinal wall.
Because symptoms can overlap, diagnostic testing is often necessary to distinguish between the two conditions.
Persistent diarrhea, rectal bleeding, unexplained weight loss, or recurring abdominal pain should be evaluated by a healthcare professional rather than assumed to be a temporary digestive problem.
Urgent medical attention may be necessary when symptoms are severe, especially when they include heavy rectal bleeding, severe abdominal pain or swelling, high fever, dehydration, weakness, fainting, or a rapid heartbeat.
Early evaluation can help identify the cause of symptoms and allow appropriate treatment before complications develop.
Definition: Ulcerative colitis is a chronic inflammatory bowel disease that causes inflammation and ulcers in the lining of the colon and rectum.
Where it occurs: The disease affects the large intestine and usually begins in the rectum.
Common symptoms: Bloody diarrhea, rectal bleeding, abdominal cramps, bowel urgency, fatigue, and weight loss.
Main causes: The exact cause is unknown, but genetic, immune, environmental, and gut-microbiome factors appear to contribute.
Diagnosis: Diagnosis typically involves medical history, physical examination, blood and stool tests, colonoscopy, and biopsy.
Treatment: Treatment may include 5-ASA medications, corticosteroids, immunomodulators, biologics, targeted therapies, nutritional support, and surgery in selected cases.
Long-term goal: The primary goals are to control inflammation, achieve remission, prevent complications, and maintain quality of life.
Ulcerative colitis is a chronic inflammatory bowel disease that affects the colon and rectum. It causes inflammation and ulcers in the intestinal lining and commonly produces bloody diarrhea, rectal bleeding, abdominal pain, and bowel urgency.
Common early symptoms include persistent diarrhea, blood or mucus in the stool, rectal bleeding, abdominal cramping, bowel urgency, and frequent bowel movements. Fatigue and weight loss can occur when inflammation is more significant or prolonged.
The exact cause is unknown. Research suggests that UC develops through interactions among genetic susceptibility, abnormal immune responses, environmental factors, and changes in the gut microbiome.
Ulcerative colitis is generally described as an immune-mediated inflammatory disease. The immune system becomes dysregulated and produces inflammation against intestinal tissue, but the exact mechanisms are complex and not completely understood.
There is currently no medication that permanently cures ulcerative colitis. However, many treatments can control inflammation and maintain remission. Removal of the colon and rectum can eliminate the intestinal disease but is a major surgical intervention.
There is no universal list of foods that everyone with UC must avoid. Food tolerance varies considerably. During active symptoms, some people may have difficulty with high-fiber foods, fatty meals, spicy foods, alcohol, or caffeine. A dietitian can help develop an individualized nutrition plan.
Stress is not considered the underlying cause of ulcerative colitis. However, significant stress may worsen symptoms or affect how a person experiences and manages the disease. Stress-management strategies can therefore be useful as part of overall care.
Yes. Long-standing ulcerative colitis, particularly when extensive portions of the colon are affected, can increase colorectal cancer risk. Recommended surveillance colonoscopies can help detect precancerous or cancerous changes earlier.
Yes. Treatment can help many people achieve remission, during which symptoms and intestinal inflammation are substantially reduced. Maintaining prescribed therapy and attending regular follow-up appointments can help reduce the likelihood of relapse.
Most people with ulcerative colitis can manage the condition effectively with appropriate treatment. However, severe disease can lead to serious complications such as severe bleeding, toxic megacolon, dehydration, or bowel perforation. Acute severe ulcerative colitis requires urgent medical care.
Ulcerative colitis affects the colon and rectum and typically produces continuous inflammation beginning in the rectum. Crohn’s disease can affect any part of the gastrointestinal tract and often produces patchy inflammation that may extend through deeper layers of the bowel wall.
American College of Gastroenterology. (n.d.). Ulcerative colitis. https://gi.org/topics/ulcerative-colitis/
Crohn’s & Colitis Foundation. (n.d.). Ulcerative colitis. https://www.crohnscolitisfoundation.org/what-is-ulcerative-colitis
National Institute of Diabetes and Digestive and Kidney Diseases. (n.d.). Ulcerative colitis. U.S. Department of Health and Human Services, National Institutes of Health. https://www.niddk.nih.gov/health-information/digestive-diseases/ulcerative-colitis
National Institute of Diabetes and Digestive and Kidney Diseases. (n.d.). Diagnosis of ulcerative colitis. U.S. Department of Health and Human Services, National Institutes of Health. https://www.niddk.nih.gov/health-information/digestive-diseases/ulcerative-colitis/diagnosis
National Institute of Diabetes and Digestive and Kidney Diseases. (n.d.). Treatment for ulcerative colitis. U.S. Department of Health and Human Services, National Institutes of Health. https://www.niddk.nih.gov/health-information/digestive-diseases/ulcerative-colitis/treatment
Turner, D., Ricciuto, A., Lewis, A., D’Amico, F., Dhaliwal, J., Griffiths, A. M., Bettenworth, D., Sandborn, W. J., Sands, B. E., Reinisch, W., Danese, S., Panaccione, R., Peyrin-Biroulet, L., Siegmund, B., Brand, E. C., Calabrese, C., Travis, S. P. L., & International Organization for the Study of IBD. (2021). STRIDE-II: An update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) initiative of the International Organization for the Study of IBD. Gastroenterology, 160(5), 1570–1583. https://doi.org/10.1053/j.gastro.2020.12.031
Feuerstein, J. D., Isaacs, K. L., Schneider, Y., Siddique, S. M., Falck-Ytter, Y., & Singh, S. (2020). AGA clinical practice guidelines on the management of moderate to severe ulcerative colitis. Gastroenterology, 158(5), 1450–1461. https://doi.org/10.1053/j.gastro.2020.01.006
